Wave Life Sciences (WVE) Payables (2016 - 2025)
Historic Payables for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $14.5 million.
- Wave Life Sciences' Payables rose 1337.14% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 1337.14%. This contributed to the annual value of $16.3 million for FY2024, which is 2666.1% up from last year.
- As of Q3 2025, Wave Life Sciences' Payables stood at $14.5 million, which was up 1337.14% from $14.7 million recorded in Q2 2025.
- Wave Life Sciences' Payables' 5-year high stood at $18.1 million during Q2 2024, with a 5-year trough of $7.3 million in Q4 2021.
- Moreover, its 5-year median value for Payables was $12.8 million (2024), whereas its average is $12.8 million.
- In the last 5 years, Wave Life Sciences' Payables tumbled by 4722.0% in 2021 and then soared by 13231.7% in 2022.
- Over the past 5 years, Wave Life Sciences' Payables (Quarter) stood at $7.3 million in 2021, then surged by 132.32% to $16.9 million in 2022, then dropped by 24.1% to $12.8 million in 2023, then increased by 26.66% to $16.3 million in 2024, then dropped by 10.9% to $14.5 million in 2025.
- Its last three reported values are $14.5 million in Q3 2025, $14.7 million for Q2 2025, and $14.4 million during Q1 2025.